We recently compiled a list of the 10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds. Prenetics Global Limited is one of the most promising stocks on our list.
TheFly reported on June 16 that Benchmark initiated coverage of PRE with a Buy rating and a $30 price target. The firm highlighted the company’s IM8 health and wellness brand, which targets the expanding nutritional supplements market. Benchmark noted that PRE is positioned for long-term growth through broader product offerings, expansion into related categories, diversification of marketing channels, and increasing international market penetration.
On June 10, Prenetics Global Limited reported its first quarter 2026 financial results, highlighted by strong growth from its IM8 health and longevity brand. Total revenue reached $36.0 million, including $33.8 million generated by IM8, representing substantial year-over-year and sequential growth. Encouraged by the brand’s performance, the company increased its full-year 2026 IM8 revenue outlook to between $190 million and $210 million and projected continued momentum for the second quarter.
The business also completed the sale of its digital asset holdings, generating $41.3 million in proceeds. In addition, the company outlined plans to introduce three new IM8 products in the fourth quarter of 2026 and strengthened its leadership team through the appointment of a new chief financial officer for the IM8 business.
Prenetics Global Limited is a health sciences and biotechnology company focused on consumer wellness, preventive genetics, early cancer detection, and longevity solutions, aiming to advance personalized and preventive healthcare.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years
